Another area that needs change is patent “gaming,” in which brand-name manufacturers file multiple patents on a drug in order to keep competitors out of the market. (Photo: Shutterstock)
Streamlining the pharmaceutical supply chain and getting more generic drugs to market would help consumers who can't afford prescriptions, the head of the U.S. Senate's special committee on aging said in a Bloomberg TV interview.
“There are a lot of people getting very wealthy along this supply chain,” while regular Americans are paying “crushingly high” prices for their drugs, Senator Susan Collins, a Republican from Maine, said Wednesday.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
